(Q61914940)
Statements
OMS115102 (English)
0 references
A Double-blind, Randomized, Placebo Controlled, Multicenter, Dose-finding Trial of Ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) Patients (English)
0 references
May 2008
0 references
May 2010
0 references
38
0 references
18 year
0 references
55 year
0 references